tiprankstipranks
Advertisement
Advertisement
Avalo Therapeutics Shareholders Back Directors and Governance Changes
PremiumCompany AnnouncementsAvalo Therapeutics Shareholders Back Directors and Governance Changes
8d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
19d ago
Avalo Therapeutics price target lowered to $34 from $40 at Wedbush
Premium
The Fly
Avalo Therapeutics price target lowered to $34 from $40 at Wedbush
1M ago
Avalo Therapeutics reports Q1 EPS (98c), consensus ($1.01)
PremiumThe FlyAvalo Therapeutics reports Q1 EPS (98c), consensus ($1.01)
1M ago
Avalo Therapeutics price target raised to $60 from $48 at Piper Sandler
Premium
The Fly
Avalo Therapeutics price target raised to $60 from $48 at Piper Sandler
1M ago
Avalo Therapeutics Announces Major Equity and Warrant Offering
Premium
Company Announcements
Avalo Therapeutics Announces Major Equity and Warrant Offering
1M ago
Why Is Avalo Therapeutics Stock (AVTX) Up Today?
PremiumMarket NewsWhy Is Avalo Therapeutics Stock (AVTX) Up Today?
1M ago
Julian Harrison Raises AVTX Price Target to $58 on Strong Phase 2 LOTUS Data and Differentiated Safety Profile for Abdakibart
Premium
Ratings
Julian Harrison Raises AVTX Price Target to $58 on Strong Phase 2 LOTUS Data and Differentiated Safety Profile for Abdakibart
1M ago
Avalo Therapeutics Reports Strong Phase 2 Hidradenitis Data
Premium
Company Announcements
Avalo Therapeutics Reports Strong Phase 2 Hidradenitis Data
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100